关于中枢神经系统和周围神经系统疾病中nobiletin最近进展的综述
Yueshan Pang1, Juan Xiong1, You Wu1
1Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, 637000, China.
European journal of medical research
|November 7, 2023
概括
诺比利是一种低毒性的化合物,在治疗周围神经系统疾病方面表现有前途. 研究强调其神经保护作用,建议神经疾病的新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 诺比林在神经元疾病中的治疗潜力正在引起人们的注意.
- 关于nobiletin在周围神经系统 (PNS) 中的作用的研究仍然有限.
- 诺比是一种脂溶性化合物,具有高生物可用性和低毒性.
研究的目的:
- 审查最近关于nobiletin在神经系统中的治疗潜力的研究.
- 为了突出nobiletin在保护周围神经系统中的新兴作用.
- 为神经系统疾病中的nobiletin提供新的研究方向.
主要方法:
- 关于 nobiletin. 的最新科学研究的文献综述.
- 在各种神经系统环境中分析nobiletin的生物功能.
- 关于nobiletin对神经细胞和组织的保护作用的综合证据.
主要成果:
- 诺比利丁表现出神经保护作用,包括抗炎和抗氧化特性.
- 它促进神经细胞的生存,轴突的生长,并改善记忆力.
- 研究表明,nobiletin可以保护肠道神经系统,脊髓和坐骨神经.
结论:
- 诺比林在各种神经系统疾病中显示出显著的治疗潜力.
- 对nobiletin的进一步研究可能会揭示神经系统疾病的新治疗策略.
- 它的特性使其成为神经保护和神经修复的有希望的候选人.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


